Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof

US Patent 12510550 · Granted Dec 30, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2019
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2018
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)2017
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2016
Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof2015